Eikon Therapeutics Pipeline
| Drug | Indication | Phase |
|---|
| EIK-001 | Oncology (Undisclosed) | Preclinical |
| EIK-002 | Immunology/Inflammation (Undisclosed) | Preclinical |
| EIK-003 | Oncology (Undisclosed) | Discovery |
| EIK-004 | Undisclosed | Discovery |
| EIK-005 | Undisclosed | Discovery |